Adding immunotherapy to platinum-gemcitabine chemotherapy can improve outcomes in patients with advanced urothelial carcinoma, but that may depend on the platinum agent used, data suggest.

In a prospective longitudinal trial, researchers assessed the association between academic readiness and outcomes in patients who received brain tumor treatment in early childhood.

Recently, it has been demonstrated that in B-ALL, distinct developmental states are associated with genomic alterations and clinical characteristics.

Researchers found that patients diagnosed with HCC during 2013-2019 were less likely to die from HCC or from any cause than patients who were diagnosed during 2006-2012.

During the first decade of the Affordable Care Act (ACA), survival and mortality increased among young adults with cancer who were eligible for dependent care e ...

Safety results and AE management approaches for talquetamab were reported by oncology nurses practicing at study sites participating in the MonumenTAL-1 studies.

Undergoing medical tattooing can be considered the “end” of the breast cancer journey. While they may need continued follow-up with their oncologist, by addressing the physical appearance of their ...

Medical tattooing can help patients with breast cancer rebuild a positive body image after treatment.

In the past decade, there have been significant advancements in targeted antibody-based immunotherapies for managing r/r ...

Intensive chemotherapy combined with second- or third-generation tyrosine kinase inhibitors improves survival in patients ...

Researchers sought to elucidate different patterns of disease response in pediatric patients with B-ALL vs T-ALL.

Patients who achieved a pathologic complete response after neoadjuvant therapy had better survival outcomes than patients who received adjuvant therapy.